Healthcare
FDA revises biosimilar guidelines for clearer drug labelling
The FDA released a draft guidance giving advice on the correct labelling of biosimilar and interchangeable biosimilar products.
The FDA released a draft guidance giving advice on the correct labelling of biosimilar and interchangeable biosimilar products.